Thursday, August 11, 2022
Home Special Reports

Special Reports

The importance of testing for Trichomoniasis

Here, Sekisui Diagnostics, the innovative company behind the OSOM® Trichomonas test, explore the common sexually transmitted infection, trichomoniasis, outlining key symptoms, complications, treatments and...

Defence Therapeutics’ technology optimises cancer vaccine efficacy

Biotechnology experts Defence Therapeutics are leading the fight against cancer and infectious diseases. Discover how their revolutionary drug enhancer platform is elevating cancer vaccine...

Are alcohol hand sanitisers effective against COVID-19 and PATHOGENS?

Following the sharp uptake in hand sanitiser products during the COVID-19 pandemic, Professor Nigel Silman, Visiting Chair in Infectious Disease at the University of...

The detergent-disinfectant wipe that reduces MRSA acquisitions by 55%

From infection prevention specialists GAMA Healthcare, Clinell Universal Wipes reduced MRSA acquisitions in a large teaching hospital in the UK. In 2021, new guidelines were...

Enhancing the efficacy of cancer vaccines and antibody drug conjugates

In its quest to optimise treatment for cancer and infectious diseases, Defence Therapeutics illustrates how its groundbreaking Accum technology elevates the performance of vaccines...

Low-intensity Vibration Therapy: Combatting an osteoporosis epidemic

MyBones outlines the challenges to global bone health revealed by SCOPE 2021, and how Low-intensity Vibration therapy offers an innovative way to prevent and...

Hand hygiene compliance: Manual observation is no longer acceptable

Driving improvement of the most important infection prevention practice – hand hygiene compliance. Well before COVID-19, Healthcare Acquired Infections (HAIs) were leading to mortality rates...

Combatting antimicrobial resistance with automated and fast PCR testing

Dr Beryl Oppenheim, Senior Director, Medical Affairs at Cepheid, an industry-leading company in molecular diagnostics, provides insights into how their cutting-edge technology can alleviate...

Mitigating contamination threats with microbial analysis and water testing

Nova Biologicals, a leading microbiological testing service, outlines how microscopic contaminants can be mitigated and contained through microbial analysis methods such as water testing. Microscopic...

Defence Therapeutics: Accelerating the fight against cancer and infectious diseases

Defence Therapeutics outlines how it is actively looking to continue the development of its product pipeline in partnership with large pharmaceutical companies. Defence Therapeutics, a...

XPhyto: Taking biosensors to the next level

2022 could mark a breakout year for XPhyto Therapeutics Corp. as they look at taking their rapid detection of bacterial and infectious disease technology...

Enhancing access to healthcare with point-of-care diagnostics technology

Experts in the field of blood count testing diagnostics – PixCell Medical – illustrate how their cutting-edge technology can optimise access to healthcare in...

Sysmex: Alleviating the burden of antimicrobial resistance (AMR)

The developing threat of antimicrobial resistance on global health is proving to be challenging. Sysmex Europe outlines the burden and prevention of antimicrobial resistance...

Transforming diagnostic testing for biomarkers with Egoo.health platform

Egoo.Health Platform is transforming testing for biomarkers with their diagnostics device, which delivers everyone from ordinary people to healthcare professionals, the opportunity to monitor...

One1Star Solutions revolutionising most Advanced TAED globally

One1Star Solutions introduces its groundbreaking Tetraacetylethylenediamine (TAED), an innovative solution to cleaning and disinfection needs for a vast range of sectors. One1Star Solutions has patented...

LumiraDx: Fighting antimicrobial resistance with innovative POC testing

Antimicrobial resistance (AMR) is ever-evolving and perhaps the most dangerous global health threat of modern times, an issue that will require cutting-edge innovation to...

Big Boost for NervGen’s Phase II Clinical Trials

In a groundbreaking development for paralysed people, the revolutionary NVG-291 treatment for spinal cord injury is set to undergo Phase II clinical trials in...

The challenges and opportunities associated with phage therapy

Dr Zemphira Alavidze, a medical microbiologist at Phage Therapy Center, explains the benefits and challenges associated with phage therapy. Phage Therapy Center was founded in...

Amarin: Changing the landscape of residual cardiovascular disease risk

World-leading pioneers of the pharmaceutical industry, Amarin Corporation, comprehensively explore the ever-evolving landscape of cardiovascular disease, analysing the current challenges facing mitigating the impacts...

How XPhyto Therapeutics could revolutionise PCR testing

Canadian life sciences start-up, XPhyto Therapeutics, explains how it is disrupting COVID-19 testing in Europe with its breakthrough PCR diagnostics technology. Antigen testing, though it...

Health News

Health eBooks

Health Partners

Pin It on Pinterest